Screener
Summit Therapeutics SMMT Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
FAQ
- What is Summit Therapeutics's goodwill?
- Summit Therapeutics (SMMT) reported goodwill of $1.97M in Q1 2026.
- How has Summit Therapeutics's goodwill changed year-over-year?
- Summit Therapeutics's goodwill increased by 2.2% year-over-year, from $1.92M to $1.97M.
- What is the long-term trend for Summit Therapeutics's goodwill?
- Over 5 years (2020 to 2025), Summit Therapeutics's goodwill has grown at a -0.3% compound annual growth rate (CAGR), from $2.03M to $2M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about Summit Therapeutics's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude